UQ sand mining startup named among top global innovators by World Economic Forum

A sustainable mining startup backed by UQ researchers has been recognised among a handful of top global innovators by the World Economic Forum.
12 May 2025

Researchers to take healthy oats beyond breakfast

Expanding consumption of oats beyond the usual breakfast bowl of porridge is the aim of a $5.6 million project at the Food and Beverage Accelerator.
9 May 2025

Egg injection leads to healthier chicks

An essential oil shows promise for improving the immunity of broiler chickens before they hatch, according to UQ research.
12 May 2025

Replanted rainforests may benefit from termite transplants

Despite a bad reputation for their destructive abilities, termite ‘transplants’ may be necessary to give regenerated rainforests a boost.
7 May 2025

Light conversion tech to power wearable X-rays for children

Light conversion technology developed by UQ researchers will be used for wearable X-ray devices that make respiratory scans more comfortable for young children.
6 May 2025

Packaging up a sustainable future for Australian business

Researchers at Australia’s Food and Beverage Accelerator have developed a roadmap to help Australian food and beverage businesses shift towards more eco-friendly packagin
29 April 2025

Satellites a solution for tracking coral reef health

Satellites orbiting Earth offer great potential to better understand the world’s reefs over time beyond the sites visited by researchers, UQ research has found.
30 April 2025

Markets are choppy. What should you do with your super if you are near retirement?

For Australians approaching retirement, recent market volatility may feel like more than just a bump in the road, writes UQ's Dr Natalie Peng.
24 April 2025

UQ joins $18m effort to transform prostate cancer care

UQ will play a key role in a national effort to revolutionise treatment for men with prostate cancer.
23 April 2025

World-first immunotherapy trial to treat Type 1 diabetes

Researchers at UQ have dosed 5 participants in the first clinical trial of a potentially revolutionary immunotherapy drug to treat Type 1 diabetes.
29 April 2025

Pages

Home ›